3,4-dihydroxyphenylacetic acid has been researched along with isomethyleugenol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cubeddu, LX; Ferrari, GB; Hoffmann, IS | 1 |
| Argiolas, A; Fadda, F | 1 |
| Baumann, PA; Bischoff, S; Bittiger, H; Feldtrauer, JJ; Hauser, K; von Sprecher, G; Waldmeier, PC | 1 |
| Cheng, BY; Collins, MA; Origitano, TC | 1 |
| Bhaird, NN; Fowler, CJ; Thorberg, O; Tipton, KF | 1 |
| Roth, RH | 1 |
| Da Prada, M; Napolitano, A; Zürcher, G | 1 |
| Chrapusta, SJ; Egan, MF; Karoum, F | 1 |
| Fasciano, J; Hatzidimitriou, G; Katz, JL; Ricaurte, GA; Yuan, J | 1 |
| Hainzl, D; Loureiro, AI; Parada, A; Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
| Aura, AM; Bailey, M; Nuutila, AM; O'Leary, KA; Ojala, M; Oksman-Caldentey, KM; Poutanen, K; Puupponen-Pimiä, R; Williamson, G | 1 |
| Ascherio, A; Brown-Jermyn, D; Chen, JF; Dluzen, DE; Schwarzschild, MA; Xu, K; Xu, Y | 1 |
| Ali, SF; Charlton, CG; Jiao, Y; Lamango, NS; Lee, ES; Oriaku, ET; Schmued, L; Shepherd, KR; Soliman, KF | 1 |
| García-Horsman, JA; Käenmäki, M; Kambur, O; Karvonen, E; Keisala, T; Kulesskaya, N; Männistö, PT; Rauvala, H; Tammimäki, A | 1 |
1 review(s) available for 3,4-dihydroxyphenylacetic acid and isomethyleugenol
| Article | Year |
|---|---|
CNS dopamine autoreceptors: distribution, pharmacology, and function.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; alpha-Methyltyrosine; Animals; Apomorphine; Brain; Calmodulin; Dopamine; Dopamine Antagonists; Drug Tolerance; Electrophysiology; Homovanillic Acid; Limbic System; Mesencephalon; Methylation; Methyltyrosines; Neurons; Receptors, Dopamine; Stress, Physiological; Telencephalon; Tissue Distribution | 1984 |
13 other study(ies) available for 3,4-dihydroxyphenylacetic acid and isomethyleugenol
| Article | Year |
|---|---|
Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Caudate Nucleus; Cocaine; Dopamine; Drug Interactions; In Vitro Techniques; Male; Methylation; Phenylacetates; Probenecid; Putamen; Rats; Synapses | 1979 |
A radioenzymatic method to measure picogram amounts of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in small samples of brain tissue.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catechol O-Methyltransferase; Caudate Nucleus; Dopamine; Hypothalamus; Methylation; Microchemistry; Phenylacetates; Rats; Substantia Nigra | 1978 |
CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amidines; Animals; Brain; Catechol O-Methyltransferase Inhibitors; Catechols; Clorgyline; Corpus Striatum; Female; Homovanillic Acid; In Vitro Techniques; Male; Methylation; Methyldopa; Neurotransmitter Agents; Pyridones; Pyrogallol; Rats; Rats, Inbred Strains; Tropolone | 1990 |
Inhibition of catechol-O-methyltransferase by 6,7-dihydroxy-3,4-dihydroisoquinolines related to dopamine: demonstration using liquid chromatography and a novel substrate for O-methylation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechol O-Methyltransferase Inhibitors; Chromatography, Liquid; Corpus Striatum; Dopamine; Homovanillic Acid; Hydrogen-Ion Concentration; Hydroxyindoleacetic Acid; Hydroxylation; Hypothalamus; Isoquinolines; Liver; Male; Methylation; Papaverine; Rats; Rats, Inbred Strains; Spectrophotometry; Tetrahydropapaveroline | 1987 |
Involvement of catechol-O-methyl transferase in the metabolism of the putative dopamine autoreceptor agonist 3-PPP(3-(3-hydroxyphenyl)-N-n-propylpiperidine).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechol O-Methyltransferase; Cattle; Dopamine; Kinetics; Liver; Methylation; Piperidines; Pyrogallol | 1985 |
Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Benzophenones; Catechol O-Methyltransferase Inhibitors; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Homovanillic Acid; Levodopa; Male; Methylation; Microdialysis; Neostriatum; Nitrophenols; Rats; Tolcapone | 1995 |
3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple t
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Frontal Lobe; Haloperidol; Kinetics; Male; Methylation; Models, Biological; Nucleus Accumbens; Rats; Rats, Sprague-Dawley | 1994 |
N-methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Axons; Biomarkers; Biotransformation; Brain; Discrimination, Psychological; Dopamine; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Male; Methamphetamine; Methylation; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Reference Values; Serotonin | 1997 |
BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetophenones; Animals; Biological Availability; Brain; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Homovanillic Acid; Levodopa; Male; Methylation; Rats; Rats, Wistar; Time Factors; Tyrosine | 2001 |
Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Anaerobiosis; Chromatography, High Pressure Liquid; Feces; Fermentation; Humans; Hydrogen-Ion Concentration; Kinetics; Mass Spectrometry; Methylation; Quercetin; Rutin | 2002 |
Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Caffeine; Corpus Striatum; Cytochrome P-450 CYP1A2; Dopamine; Drug Implants; Estradiol; Estrogen Replacement Therapy; Female; Male; Methylation; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Ovariectomy; Parkinsonian Disorders; Sex Characteristics | 2006 |
The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Drug Synergism; Herbicides; Homovanillic Acid; Humans; Male; Methylation; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neurotoxins; Paraquat | 2006 |
Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Carbidopa; Catechol O-Methyltransferase; Dopamine; Drug Combinations; Extracellular Space; Female; Levodopa; Male; Methylation; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Mutation; Phenotype; Sensory Gating; Sex Factors; Social Dominance | 2010 |